AzTrials
AzTrials

Fatal OutcomeNCT02810366

Physician Versus Computer Coding of Verbal Autopsies

A study testing Physician versus Computer Coded Verbal Autopsy in people with Fatal Outcome, run by Centre for Global Health Research, Toronto at 3 sites in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this study is to compare the performance of computer-coded verbal autopsies (CCVA) to physician-coded verbal autopsies (PCVA) at the population level. In order to do so a randomised control trial is being conducted in five districts of India. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Fatal Outcome
What is being tested?
Physician versus Computer Coded Verbal Autopsy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12,500 participants
Where
3 sitesIndia
Study dates
Sep 2015to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All deaths that have occurred in the last five years

Who cannot join

  • None

Trial locations and contacts

3 sites in 1 country.

Rehana Begum, MD contact

+919945908671

BegumR@smh.ca

Prabhat Jha, MD, PhD contact

+14168646042

prabhat.jha@utoronto.ca

India3 sites, 2 recruiting
  • HM Patel Center for Medical Care and Education

    Karamsad, Gujarat, 388325

    Dinesh Kumar, MD, drdineshkl@charutarhealth.org

    Recruiting
  • Tata Memorial Centre

    Mumbai, Maharashtra, 400 012

    Atul Budukh, MD, +91-9920863064, atul.budukh@gmail.com

    Recruiting
  • International Institute of Population Sciences

    Mumbai, Maharashtra, 400 088

    Completed

Other trials in India

About this study

Official title: Physician Versus Computer Coding of Verbal Autopsies, a Randomised Control Trial

The objective of this study is to compare the performance of computer-coded verbal autopsies (CCVA) to physician-coded verbal autopsies (PCVA) at the population level. In order to do so a randomised control trial is being conducted in five districts of India. In each district, 50% of deaths are randomly selected for PCVA and the rest for CCVA. The cause of death distribution for both groups are then compared within each district. If the performance of PCVA and CCVA are comparable, the attained distributions should be similar.

Read the detailed description

BACKGROUND

Most deaths in low and middle-income countries occur out of hospital and without medical attention and certification at the time of death. Hence, information on causes of death (COD) is lacking. In these settings, verbal autopsies (VAs), typically involving lay non-medical interviews of living family members or close associates of the deceased about the details of death, with subsequent assignment of COD by physician, can be used to estimate COD patterns.

Although VA is being commonly used for acquiring community-based COD data, its application and mode of assignment of COD may vary. The choice of physician-certified verbal autopsy (PCVA) coding versus computer-coded verbal autopsy methods (CCVA) has been widely debated. Both these methods have limitations. While PCVA methods suffer from inter and intra-observer differences in coding in addition to physician time consumption and expense, the accuracy of CCVA methods which are faster and less expensive than PCVA have not been assessed in different settings. A literature search yielded only one study that have systematically assessed the performance of four computer-coded verbal autopsy methods for COD assignment compared with physician coding of VAs on 24,000 deaths in low and middle-income countries (Miasnikof et al. 2015).

Here the investigators propose the first ever randomised control trial assessing PCVA versus CCVA at the population level.

STUDY DESIGN

This randomised control trial will be conducted in three states of India; a total of 12,500 deaths that occurred in the last five years will be collected via VA. In each district (five districts across the three states - see below), 50% of deaths are randomly selected for PCVA and the rest for CCVA. The COD distribution for both groups are then compared within each district. If the performance of PCVA and CCVA are comparable, the attained distributions should be similar.

Study districts in India (x number of anticipated VAs to be collected from approx. y number of households):

  • Amravati, Maharashtra (2500 VAs from ~12,500 households)
  • Anand and Kheda districts, Gujarat (5000 VAs from ~25,000 households)
  • Sangrur and Mansa districts, Punjab (5000 VAs from ~25,000 households)

OBJECTIVES

  • Primary Objective: To assess physician versus computer coding of VAs at the population level - Do computer algorithms perform as well as physician coding of VAs when determining the COD distribution at the population level.
  • Secondary Objective: To assess the quality of physician versus lay surveyor VA data collection - Does the quality of symptom information collected or final COD assigned differ when a physician versus a lay person carries out the VA data collection.
  • Tertiary Objective: To assess household preference of short VA questionnaire with narrative versus a long questionnaire without a narrative - Which VA instrument do households prefer.

DATA COLLECTION

Data collection for the study will proceed in two phases.

  • Phase 1: Enumeration and VA (short questionnaire with narrative, and long questionnaire with narrative) by lay data collectors. VA questionnaires were designed based on World Health Organization (WHO) recommendations.
  • Phase 2: Physician re-sampling for 50% of the VAs to be used for PCVA The data will be collected using a laptop/tablet in an electronic format in the local language.

Quality control/Quality Assurance:

  1. Random 2-5% of cases will be re-interviewed by surveyors with the Quality Control Survey
  2. An audio recording of the entire data collection will be done for quality control and monitoring.

ANALYSIS PLAN

  • Primary Objective: COD for 50% of VAs will be assigned by trained physicians using the Million Death Study (MDS) physician coding system; this includes dual, independent coding of VA records, disagreements resolved by reconciliation, and remaining cases by adjudication by a third physician. The assignment of CODs will be in line with the international classification of disease version 10 (ICD-10). The remaining 50% of deaths will be independently assigned COD by five leading CCVA algorithms. If the performance of PCVA and CCVA are comparable, the attained COD distributions at the population level should be similar, this "similarity" will be assessed by calculating the Cause Specific Mortality Fraction (CSMF) Accuracy for each algorithm's COD assignment in each district against the CSMF of the PCVAs in the respective district.
  • Secondary Objective: Half of the PCVAs in each district will be re-interviewed by physicians, and CODs will be assigned to these re-interviewed VAs using the MDS physician coding system described above. To assess concordance of COD assignment between lay person and physician collected VAs, the CSMF Accuracy will be calculated to determine concordance at the population level, while Sensitivity and Partial Chance Corrected Concordance (PCCC) will be calculated to assess similarity of COD assignment at the individual level.
  • Tertiary Objective: Respondents cooperation with the short VA questionnaire with narrative versus the long questionnaire without a narrative will be assessed to determine which VA instrument households prefer. A focus group with surveyors to receive their feedback on using both instruments in the field will also be conducted.

The results of this study will be presented as three separate trials (one trial per state). The results of the first trial will be used for hypothesis generation.

Conditions
Fatal Outcome
Being tested
Physician versus Computer Coded Verbal Autopsy
Keywords
Verbal Autopsy, Physician-coded verbal autopsy, Computer-coded verbal autopsy, InterVA, Naive Bayes Classifier (NBC), Tariff, InSilicoVA, Randomised Control Trial, SmartVA, King-Lu

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physician versus Computer Coded Verbal AutopsyOther

    Also called PCVA vs. CCVA

    Comparing the performance of computer coded verbal autopsies (CCVA) to physician coded verbal autopsies (PCVA) at the population level.

Study groups in NCT02810366
Study groupRoleWhat they receive
Physician Coded Verbal AutopsyActive comparatorOf the approximately 12,500 VAs collected, 50% in each district will be randomly collected using the "electronic Verbal Autopsy" (eVA) instrument. In addition to "general information" about the deceased (e.g. name, sex, age, etc.), this VA instrument contains a short checklist questionnaire to capture from the respondent the signs and symptoms noted during the final illness, followed by a free-text narrative. Cause of death for these VAs will be assigned by trained physicians using the MDS physician coding system; this includes dual, independent coding of VA records, disagreements resolved by reconciliation, and remaining cases by adjudication by a third physician. The assignment of cause of deaths will be in line with the international classification of disease version 10 (ICD-10).
Receives: Other: Physician versus Computer Coded Verbal Autopsy
Computer Coded Verbal AutopsyExperimentalOf the approximately 12,500 VAs collected, 50% in each district will be randomly collected using the "Extended Symptom List" (ESL) VA instrument. In addition to "general information" about the deceased (e.g. name, sex, age, etc.), this VA instrument contains a long checklist questionnaire to capture from the respondent the signs and symptoms noted during the final illness. This VA instrument does not contain a free-text narrative. The cause of death for these VAs will be independently assigned by five leading computer-coding VA algorithms. The assignment of cause of deaths will be in line with 17 broad cause of death categories.
Receives: Other: Physician versus Computer Coded Verbal Autopsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Equivalence (CSMF Accuracy) of cause of death distribution between physician versus computer coded verbal autopsies

    Use CSMF Accuracy to measure the equivalence of the cause of death distribution between the physician and computer coded VA arms of this study, in order to assess whether the performance of physician vs. computer coding of VAs are comparable at the population level

    Measured: 1 year

Secondary outcomes (1)
  1. Equivalence of cause of death assignment at the population (CSMF Accuracy) and individual (sensitivity) levels of physician versus lay surveyor collected verbal autopsies

    For each of the deaths for which a VA was independently collected by a physician and a lay person, calculate the CSMF Accuracy and sensitivity of the causes of death assigned to these VAs, in order to assess if the final cause of death assigned differs when a physician versus a lay person conducts the VA data collection

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2016 (estimated)
  2. Study startSep 2015
  3. Primary completionSep 2016 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
12,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02810366
Sponsor's protocol ID
PCVA vs CCVA
Status last verified
Jun 2016
First submitted
11 Apr 2016
Last updated
23 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: Personal identifiers within each collected verbal autopsy will be anonymized. This anonymized dataset will be made publically available.

Publications

  • Leitao J, Desai N, Aleksandrowicz L, Byass P, Miasnikof P, Tollman S, Alam D, Lu Y, Rathi SK, Singh A, Suraweera W, Ram F, Jha P. Comparison of physician-certified verbal autopsy with computer-coded verbal autopsy for cause of death assignment in hospitalized patients in low- and middle-income countries: systematic review. BMC Med. 2014 Feb 4;12:22. doi: 10.1186/1741-7015-12-22.

    PubMed 24495312
  • Desai N, Aleksandrowicz L, Miasnikof P, Lu Y, Leitao J, Byass P, Tollman S, Mee P, Alam D, Rathi SK, Singh A, Kumar R, Ram F, Jha P. Performance of four computer-coded verbal autopsy methods for cause of death assignment compared with physician coding on 24,000 deaths in low- and middle-income countries. BMC Med. 2014 Feb 4;12:20. doi: 10.1186/1741-7015-12-20.

    PubMed 24495855
  • Miasnikof P, Giannakeas V, Gomes M, Aleksandrowicz L, Shestopaloff AY, Alam D, Tollman S, Samarikhalaj A, Jha P. Naive Bayes classifiers for verbal autopsies: comparison to physician-based classification for 21,000 child and adult deaths. BMC Med. 2015 Nov 25;13:286. doi: 10.1186/s12916-015-0521-2.

    PubMed 26607695
  • Jha P, Kumar D, Dikshit R, Budukh A, Begum R, Sati P, Kolpak P, Wen R, Raithatha SJ, Shah U, Li ZR, Aleksandrowicz L, Shah P, Piyasena K, McCormick TH, Gelband H, Clark SJ. Automated versus physician assignment of cause of death for verbal autopsies: randomized trial of 9374 deaths in 117 villages in India. BMC Med. 2019 Jun 27;17(1):116. doi: 10.1186/s12916-019-1353-2.

    PubMed 31242925

Questions about this trial

What is this clinical trial studying?

A study testing Physician versus Computer Coded Verbal Autopsy in people with Fatal Outcome, run by Centre for Global Health Research, Toronto at 3 sites in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rehana Begum, MD (+919945908671, BegumR@smh.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Equivalence (CSMF Accuracy) of cause of death distribution between physician versus computer coded verbal autopsies (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02810366, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in